Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2012 2
2013 1
2015 2
2016 2
2017 3
2018 3
2019 5
2020 3
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators. Richardson PG, et al. Lancet Oncol. 2019 Jun;20(6):781-794. doi: 10.1016/S1470-2045(19)30152-4. Epub 2019 May 13. Lancet Oncol. 2019. PMID: 31097405 Clinical Trial.
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Moreau P, Masszi T, Grzasko N, Bahlis NJ, Hansson M, Pour L, Sandhu I, Ganly P, Baker BW, Jackson SR, Stoppa AM, Simpson DR, Gimsing P, Palumbo A, Garderet L, Cavo M, Kumar S, Touzeau C, Buadi FK, Laubach JP, Berg DT, Lin J, Di Bacco A, Hui AM, van de Velde H, Richardson PG; TOURMALINE-MM1 Study Group. Moreau P, et al. N Engl J Med. 2016 Apr 28;374(17):1621-34. doi: 10.1056/NEJMoa1516282. N Engl J Med. 2016. PMID: 27119237 Free article. Clinical Trial.
Gastric MALT Lymphoma: A 8-Year Experience.
Couto ME, Oliveira I, Domingues N, Viterbo L, Martins Â, Moreira I, Espírito Santo A, Chacim S, Moreira C, Pereira D, Henrique R, Mariz J. Couto ME, et al. Among authors: viterbo l. Indian J Hematol Blood Transfus. 2022 Jul;38(3):492-498. doi: 10.1007/s12288-021-01483-0. Epub 2021 Aug 26. Indian J Hematol Blood Transfus. 2022. PMID: 35747568 Free PMC article.
Tail wound in a dog: A rare arterial catheter complication.
Viterbo L, Hughes J, Medina-Serra R. Viterbo L, et al. Vet Anaesth Analg. 2023 Jan;50(1):102-104. doi: 10.1016/j.vaa.2022.10.004. Epub 2022 Nov 3. Vet Anaesth Analg. 2023. PMID: 36496328 No abstract available.
Gastric Diffuse Large B-Cell Lymphoma: A Single-Center 9-Year Experience.
Couto ME, Oliveira I, Domingues N, Viterbo L, Martins Â, Moreira I, Espírito-Santo A, Chacim S, Moreira C, Pereira D, Henrique R, Mariz J. Couto ME, et al. Among authors: viterbo l. Indian J Hematol Blood Transfus. 2021 Jul;37(3):492-496. doi: 10.1007/s12288-020-01391-9. Epub 2021 Jan 2. Indian J Hematol Blood Transfus. 2021. PMID: 33424149 Free PMC article.
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients.
Avet-Loiseau H, Bahlis NJ, Chng WJ, Masszi T, Viterbo L, Pour L, Ganly P, Palumbo A, Cavo M, Langer C, Pluta A, Nagler A, Kumar S, Ben-Yehuda D, Rajkumar SV, San-Miguel J, Berg D, Lin J, van de Velde H, Esseltine DL, di Bacco A, Moreau P, Richardson PG. Avet-Loiseau H, et al. Among authors: viterbo l. Blood. 2017 Dec 14;130(24):2610-2618. doi: 10.1182/blood-2017-06-791228. Epub 2017 Oct 20. Blood. 2017. PMID: 29054911 Free article. Clinical Trial.
Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.
Ludwig H, Greil R, Masszi T, Spicka I, Shpilberg O, Hajek R, Dmoszynska A, Paiva B, Vidriales MB, Esteves G, Stoppa AM, Robinson D Jr, Chaturvedi S, Ataman O, Enny C, Feng H, van de Velde H, Viterbo L. Ludwig H, et al. Among authors: viterbo l. Br J Haematol. 2015 Nov;171(3):344-54. doi: 10.1111/bjh.13582. Epub 2015 Jul 7. Br J Haematol. 2015. PMID: 26153365 Free PMC article. Clinical Trial.
Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia.
Espirito Santo A, Chacim S, Ferreira I, Leite L, Moreira C, Pereira D, Dantas M, Nunes M, Viterbo L, Moreira I, Martins A, Oliveira I, Domingues N, Mariz J, Medeiros R. Espirito Santo A, et al. Among authors: viterbo l. Mol Clin Oncol. 2017 Mar;6(3):384-388. doi: 10.3892/mco.2017.1134. Epub 2017 Jan 20. Mol Clin Oncol. 2017. PMID: 28451418 Free PMC article.
25 results